A-share market opens express | A-share market opens high and falls low, AI application direction continues to lead the rise! Commercial aerospace sector encounters a wave of trading halts.
On January 13th, the three major indexes opened higher but fell during the day. As of the time of writing, the Shanghai Composite Index fell 0.57%, the Shenzhen Component Index fell 0.63%, and the ChiNext Index fell 0.59%.
On January 13th, the three major indexes opened higher and then fell. As of the time of writing, the Shanghai Composite Index fell by 0.57%, the Shenzhen Component Index fell by 0.63%, and the ChiNext Index fell by 0.59%.
In terms of market performance, AI applications such as GEO and pharmaceuticals led the market higher. Stocks like Easy Click Worldwide Network Technology, Nanjing Tdh Technology, and Dian Diagnostics Group all hit their daily limit up. Concept stocks related to innovative drugs also performed well, with PharmaResources hitting the limit up. However, the commercial aerospace sector saw declines in stocks such as Western Metal Materials and Beijing LeiKe Defense Technology.
Currently, the market remains concerned about the risk of correction after sustained increases in trading volume. Zhongtai believes that long-term funds will provide support, and market activity may remain active due to policy support. Orient believes that historically, a sustained increase in trading volume can lead to market fluctuations, especially as the Shanghai Composite Index hits 17 consecutive days of gains and approaches 4200 points.
Hot sectors include:
1. AI applications leading the market up, with stocks like GEO and pharmaceuticals performing well.
2. Concept stocks related to innovative drugs showing strength, with stocks like PharmaResources hitting the limit up.
3. Institutional views: Zhongtai believes that long-term funds will support the market, while Orient sees the current market trend as healthy.
Other points mentioned in the article include updates on AI technology, the strength of concept stocks related to innovative drugs, and the cancellation of tax rebates for solar panel exports.
Related Articles
.png)
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.

HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.
.png)
HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


